In a significant number of cases a recurring t(11;19) translocation with an associated novel fusion oncogene (CRTC1-MAML2) is present.     ///    t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma..     ///    "The CRTC1-MAML2 oncogene acts as a transcription factor on Notch and CREB regulatory pathways, disrupting normal cell-cycle and differentiation, contributing to tumour development. "    ///    "Data suggest that in MEC, the presence of CRTC1-MAML2 may have some prognostic value. "    ///    A review of CRTC1-MAML2 in MEC is presented.. 